Peter J. Smith

Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears

Andreas H. Diacon, R. F. Patientia, Amour Venter et al. · Antimicrobial Agents and Chemotherapy · 2007 · 196 citations · Full text

Pulmonary Tuberculosis Evidenced, Higher Rifampin Doses, High-dose Rifampin +13

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

Justin Wilkins, Radojka M. Savić, Mats O. Karlsson et al. · Antimicrobial Agents and Chemotherapy · 2008 · 147 citations · Full text

The <i>SLCO1B1</i> rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications

Emmanuel Chigutsa, Marianne E Visser, Paolo Denti et al. · Antimicrobial Agents and Chemotherapy · 2011 · 146 citations · Full text

South Africans, Genetic Epidemiology, Immunology +20

Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis

Emmanuel Chigutsa, Jotam G. Pasipanodya, Marianne E. Visser et al. · Antimicrobial Agents and Chemotherapy · 2014 · 132 citations · Full text

Tuberculosis Prevention, Antimicrobial Chemotherapy, Nonlinear Interactions +21

Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing Guidelines

Helen McIlleron, Marianne Willemse, Cedric J. Werely et al. · Clinical Infectious Diseases · 2009 · 118 citations · Full text